Neurovascular Device Market

Neurovascular Device Market Outlook from 2024 to 2034

In the latest report by Future Market Insights, the lead research consultant estimates the global Neurovascular Device market value to reach USD 3.0 billion in 2024.

The upward trajectory will continue securing growth, with projections indicating a market value of USD 3.9 billion by 2034. This equates to a moderate CAGR of 2.7% through the forecast period.

Attributes	Key Insights
Neurovascular Device Market Estimated Size in 2024	USD 3.0 billion
Projected Market Value in 2034	USD 3.9 billion
Value-based CAGR from 2024 to 2034	2.7%

Market Trends and Highlights

• Surging incidence of neurovascular is a factor that will pave the way for market during the forecast period.
• Increasing technological advancements in neurovascular devices, is pacing up the market prospects.
• Growing demand for minimally invasive procedures, is among the factors that is advancing swiftly towards market expansion.
• Rising awareness as well as screening programs is also gaining momentum to propel the market.

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projections

The scope for neurovascular device rose at a 5.1% CAGR between 2019 and 2023. The global market is achieving heights to grow at a moderate CAGR of 2.7% over the forecast period 2024 to 2034. Several advancements were made in the neurovascular equipment category, during the historical period, such as the creation of new stent designs, embolization techniques as well as imaging technologies.

Increasing prevalence of neurovascular diseases including stroke, aneurysms, and AVMs across the globe also contributed to the increasing demand for neurovascular devices. Patients as well as the healthcare providers shifted their preference towards the minimally invasive procedures as compared to traditional surgeries, owing to their low risks implications, shorter recovery periods and better diagnostic advantages.

Healthcare spending is projected is all set to climb up particularly in developing countries in the coming years. The increased investment will augment the demand for neurovascular devices and drive market expansion.

Regulatory reforms aimed at streamlining the approval process for medical devices and ensuring patient safety will facilitate market access for neurovascular device manufacturers.

Faster regulatory approvals and expanded reimbursement coverage will drive market growth and innovation. Advances in genomics, proteomics, as well as imaging technologies will accelerate the adoption of personalized medicine approaches in neurovascular care. Neurovascular devices tailored to individual patient characteristics and disease profiles will become increasingly important, leading to market growth.

Neurovascular Device Market Key Drivers

• Expanding geriatric population will create the lucrative opportunities for the neurovascular device market.
• Strategic collaborations and partnerships scale up the demand for neurovascular device.
• Favorable reimbursement policies, are accelerating the demand for neurovascular device.
• Focus on patient outcomes and quality of life is a major factor that is paving the way for market growth.

Challenges in the Neurovascular Device Market

• High cost of neurovascular procedures is resulting in the downfall of the market.
• Stringent regulatory requirements, is another factor that is causing a reduction in the viability of the market.
• One of the major market restraining factors includes the risk of complications as well as adverse events.
• Limited access to advanced healthcare facilities, can be a challenge, showing red signs to the market.

Country-wise Insights

The below table showcases revenues in terms of the top 5 leading countries, spearheaded by India and Thailand. The countries will lead the market through 2034.

Countries	Forecast CAGRs from 2024 to 2034
The United States	1.4%
Germany	2.2%
France	3.3%
Thailand	3.4%
India	5.5%

Technological Advancements Paving the Way for the Market in the United States

The neurovascular device market in the United States will expand at a CAGR of 1.4% through 2034. The country is a hub for medical innovation, with ongoing advancements in neurovascular devices such as stents, embolic coils, thrombectomy devices, and flow diverters.

The technological innovations improve the efficacy, safety, and outcomes of neurovascular interventions, augmenting the market growth. The United States has a significant burden of neurovascular diseases such as stroke, aneurysms, and arteriovenous malformations.

There is a growing demand for neurovascular devices to treat and manage these diseases, with an aging population and changing lifestyles contributing to the rise in these conditions.

Government Initiatives and Funding to Ride the Waves in in the United Kingdom

The neurovascular device market in the United Kingdom to expand at a CAGR of 2.2% through 2034. Government initiatives aimed at improving stroke care and reducing the burden of neurovascular diseases contribute to market growth.

Funding for stroke prevention programs, research grants, and investments in healthcare infrastructure further bolster the neurovascular device market in the country.

The United Kingdom has a well-developed healthcare infrastructure, including advanced hospitals, specialized neurovascular centers, and skilled healthcare professionals. The infrastructure supports the diagnosis, treatment, and management of neurovascular diseases, creating a conducive environment for market growth.

Increasing Aging Population Heads toward Success in France

Neurovascular device trends in France are taking a turn for the better. A 3.3% CAGR is forecast for the country from 2024 to 2034. France has an aging population, which is more susceptible to neurovascular diseases.

The growing elderly population increases the demand for neurovascular interventions and devices to manage conditions such as stroke and cerebral aneurysms.

Public awareness campaigns and educational programs raise awareness about the signs, symptoms, and risk factors associated with neurovascular diseases. Increased awareness leads to earlier diagnosis and treatment, driving the demand for neurovascular devices in France.

Medical Tourism Raises the Market Expansion in Thailand

The neurovascular device market in Thailand is poised to expand at a CAGR of 3.4% through 2034. Thailand has emerged as a popular destination for medical tourism due to its high quality healthcare services, affordable costs, and well trained medical professionals.

The influx of medical tourists seeking neurovascular treatments creates additional demand for neurovascular devices and procedures, accelerating the market growth. Increasing healthcare expenditure, both public and private in Thailand, reflects the growing investment in healthcare infrastructure, technology, and services.

The higher healthcare spending contributes to the expansion of neurovascular services and the adoption of advanced medical devices, including neurovascular devices.

Expanding Health Insurance Coverage to Enhance Prospects in India

The neurovascular device market in India will expand at a CAGR of 5.5% through 2034. The expansion of health insurance coverage in India, both through government schemes and private insurance providers, improves access to healthcare services for a larger segment of the population.

The affordability of neurovascular treatments increases, with more people covered by health insurance, stimulating market growth for neurovascular devices. India is increasingly becoming a hub for medical research and innovation, with the government and private sector investing in research and development initiatives.

The development of indigenous neurovascular devices, as well as collaborative research projects with international partners, leads to the introduction of innovative products tailored to the Indian market, stimulating market growth.

Category-wise Insights

The below table highlights how aneurysm coiling and embolization segment is leading the market in terms of product type, and will account for a share of 31.7% in 2024.

Based on disease pathology, the cerebral aneuryms segment is gaining heights and will to account for a share of 26.9% in 2024.

Category	Shares in 2024
Aneurysm Coiling and Embolization	31.7%
Cerebral Aneuryms	26.9%

Aneurysm Coiling and Embolization Witnesses High Demand for Neurovascular Device

Based on product type, the aneurysm coiling and embolization segment will dominate the neurovascular device market. Aneurysms, particularly intracranial aneurysms, are a significant health concern globally.

The growing incidence of aneurysms, coupled with advancements in imaging technologies leading to better detection rates, is propelling the demand for aneurysm coiling and embolization devices. Aneurysm coiling and embolization procedures offer minimally invasive alternatives to traditional surgical treatments for aneurysms.

Patients and healthcare providers increasingly prefer these less invasive procedures due to their lower risk of complications, shorter recovery times, and better outcomes, thus boosting the demand for related devices.

Cerebral Aneuryms Segment to Hold High Demand for Neurovascular Device

In terms of disease pathology, the cerebral aneuryms segment will dominate the neurovascular device market. Technological advancements in aneurysm coiling and embolization devices have significantly improved treatment outcomes for cerebral aneurysms.

Innovations such as detachable coils, flow diverters, and intrasaccular devices offer more effective and minimally invasive options for managing cerebral aneurysms, thereby driving segmental growth.

Cerebral aneurysms are a common and serious neurovascular condition, with a significant proportion of cases leading to potentially life threatening complications such as subarachnoid hemorrhage. The increasing incidence of cerebral aneurysms globally is a primary driver for the growth of this segment.

Competitive Landscape

The neurovascular device market is characterized by intense competition among key players striving to maintain or enhance their market share through strategic initiatives, product innovation, and differentiation strategies.

Company Portfolio

• Medtronic offers a comprehensive range of neurovascular devices including stents, embolic coils, thrombectomy devices, flow diverters, and neurovascular catheters. Their products are designed to address various neurovascular conditions such as stroke, cerebral aneurysms, and arteriovenous malformations.
• Penumbra specializes in neurovascular and peripheral vascular devices for the treatment of stroke, cerebral aneurysms, and other vascular diseases. Their portfolio includes aspiration systems, thrombectomy devices, embolization coils, and flow diverters.

Key Coverage in the Neurovascular Device Industry Report

• Neurovascular interventions
• Endovascular therapy
• Stroke treatment devices
• Cerebral aneurysm management
• Intracranial stents
• Embolic coil systems
• Thrombectomy devices
• Intracranial hemorrhage management
• Interventional Neurology Market
• Neurointerventional Radiology Market
• Neurosurgery Devices Market
• Interventional Cardiology Market
• Vascular Closure Devices Market
• Neurostimulation Devices Market

Report Scope

Attribute	Details
Estimated Market Size in 2024	USD 3.0 billion
Projected Market Valuation in 2034	USD 3.9 billion
Value-based CAGR 2024 to 2034	2.7%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in USD Billion
Key Regions Covered	North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East & Africa
Key Market Segments Covered	Product, Disease Pathology, End User, Region
Key Countries Profiled	The United States, Canada, Brazil, Mexico, Germany, France, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel
Key Companies Profiled	Medtronic; Penumbra, Inc.; Stryker; Johnson and Johnson Services, Inc.; MicroPort Scientific Corporation; Acandis GmbH; MicroVention, Inc.; NeuroVasc Technologies, Inc.; Asahi Intecc USA, Inc.; Perflow Medical Ltd.

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Device
  • 5.1. Cerebral Embolization and Aneurysm Coiling Devices
    • 5.1.1. Embolic Coils
    • 5.1.2. Flow Diversion Devices
    • 5.1.3. Liquid Embolic Agents
  • 5.2. Cerebral Angioplasty and Stenting Systems
    • 5.2.1. Carotid Artery Stents
    • 5.2.2. Embolic Protection
  • 5.3. Neurothrombectomy Devices
    • 5.3.1. Clot Retrieval Devices
    • 5.3.2. Suction Devices/Aspiration Catheters
    • 5.3.3. Vascular Snares
  • 5.4. Support Devices
    • 5.4.1. Micro Catheters
    • 5.4.2. Micro Guidewires
  • 5.5. Trans Radial Access Devices
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Disease Pathology
  • 6.1. Ischemic Strokes
  • 6.2. Cerebral Aneurysm
  • 6.3. Carotid Artery Stenosis
  • 6.4. Arteriovenous Malformations
  • 6.5. Fistulas
  • 6.6. Others
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User
  • 7.1. Hospitals & Surgical Centres
  • 7.2. Ambulatory Care Centres
  • 7.3. Research Laboratories
  • 7.4. Academic Institutes
• 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 8.1. North America
  • 8.2. Latin America
  • 8.3. Western Europe
  • 8.4. Eastern Europe
  • 8.5. South Asia and Pacific
  • 8.6. East Asia
  • 8.7. Middle East and Africa
• 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 16. Key Countries Market Analysis
• 17. Market Structure Analysis
• 18. Competition Analysis
  • 18.1. Medtronic
  • 18.2. Penumbra, Inc.
  • 18.3. Stryker
  • 18.4. Johnson and Johnson Services, Inc.
  • 18.5. MicroPort Scientific Corporation
  • 18.6. Acandis GmbH
  • 18.7. MicroVention, Inc.
  • 18.8. NeuroVasc Technologies, Inc.
  • 18.9. Asahi Intecc USA, Inc.
  • 18.10. Perflow Medical Ltd.
• 19. Assumptions & Acronyms Used
• 20. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Device, 2019 to 2034

Table 4: Global Market Volume (Units) Forecast by Device, 2019 to 2034

Table 5: Global Market Value (US$ Million) Forecast by Disease Pathology, 2019 to 2034

Table 6: Global Market Volume (Units) Forecast by Disease Pathology, 2019 to 2034

Table 7: Global Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 8: Global Market Volume (Units) Forecast by End-User, 2019 to 2034

Table 9: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 10: North America Market Volume (Units) Forecast by Country, 2019 to 2034

Table 11: North America Market Value (US$ Million) Forecast by Device, 2019 to 2034

Table 12: North America Market Volume (Units) Forecast by Device, 2019 to 2034

Table 13: North America Market Value (US$ Million) Forecast by Disease Pathology, 2019 to 2034

Table 14: North America Market Volume (Units) Forecast by Disease Pathology, 2019 to 2034

Table 15: North America Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 16: North America Market Volume (Units) Forecast by End-User, 2019 to 2034

Table 17: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 18: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034

Table 19: Latin America Market Value (US$ Million) Forecast by Device, 2019 to 2034

Table 20: Latin America Market Volume (Units) Forecast by Device, 2019 to 2034

Table 21: Latin America Market Value (US$ Million) Forecast by Disease Pathology, 2019 to 2034

Table 22: Latin America Market Volume (Units) Forecast by Disease Pathology, 2019 to 2034

Table 23: Latin America Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 24: Latin America Market Volume (Units) Forecast by End-User, 2019 to 2034

Table 25: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 26: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034

Table 27: Western Europe Market Value (US$ Million) Forecast by Device, 2019 to 2034

Table 28: Western Europe Market Volume (Units) Forecast by Device, 2019 to 2034

Table 29: Western Europe Market Value (US$ Million) Forecast by Disease Pathology, 2019 to 2034

Table 30: Western Europe Market Volume (Units) Forecast by Disease Pathology, 2019 to 2034

Table 31: Western Europe Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 32: Western Europe Market Volume (Units) Forecast by End-User, 2019 to 2034

Table 33: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 34: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034

Table 35: Eastern Europe Market Value (US$ Million) Forecast by Device, 2019 to 2034

Table 36: Eastern Europe Market Volume (Units) Forecast by Device, 2019 to 2034

Table 37: Eastern Europe Market Value (US$ Million) Forecast by Disease Pathology, 2019 to 2034

Table 38: Eastern Europe Market Volume (Units) Forecast by Disease Pathology, 2019 to 2034

Table 39: Eastern Europe Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 40: Eastern Europe Market Volume (Units) Forecast by End-User, 2019 to 2034

Table 41: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 42: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034

Table 43: South Asia and Pacific Market Value (US$ Million) Forecast by Device, 2019 to 2034

Table 44: South Asia and Pacific Market Volume (Units) Forecast by Device, 2019 to 2034

Table 45: South Asia and Pacific Market Value (US$ Million) Forecast by Disease Pathology, 2019 to 2034

Table 46: South Asia and Pacific Market Volume (Units) Forecast by Disease Pathology, 2019 to 2034

Table 47: South Asia and Pacific Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 48: South Asia and Pacific Market Volume (Units) Forecast by End-User, 2019 to 2034

Table 49: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 50: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034

Table 51: East Asia Market Value (US$ Million) Forecast by Device, 2019 to 2034

Table 52: East Asia Market Volume (Units) Forecast by Device, 2019 to 2034

Table 53: East Asia Market Value (US$ Million) Forecast by Disease Pathology, 2019 to 2034

Table 54: East Asia Market Volume (Units) Forecast by Disease Pathology, 2019 to 2034

Table 55: East Asia Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 56: East Asia Market Volume (Units) Forecast by End-User, 2019 to 2034

Table 57: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 58: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034

Table 59: Middle East and Africa Market Value (US$ Million) Forecast by Device, 2019 to 2034

Table 60: Middle East and Africa Market Volume (Units) Forecast by Device, 2019 to 2034

Table 61: Middle East and Africa Market Value (US$ Million) Forecast by Disease Pathology, 2019 to 2034

Table 62: Middle East and Africa Market Volume (Units) Forecast by Disease Pathology, 2019 to 2034

Table 63: Middle East and Africa Market Value (US$ Million) Forecast by End-User, 2019 to 2034

Table 64: Middle East and Africa Market Volume (Units) Forecast by End-User, 2019 to 2034

List of Figures

Figure 1: Global Market Value (US$ Million) by Device, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by Disease Pathology, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by End-User, 2024 to 2034

Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 6: Global Market Volume (Units) Analysis by Region, 2019 to 2034

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 9: Global Market Value (US$ Million) Analysis by Device, 2019 to 2034

Figure 10: Global Market Volume (Units) Analysis by Device, 2019 to 2034

Figure 11: Global Market Value Share (%) and BPS Analysis by Device, 2024 to 2034

Figure 12: Global Market Y-o-Y Growth (%) Projections by Device, 2024 to 2034

Figure 13: Global Market Value (US$ Million) Analysis by Disease Pathology, 2019 to 2034

Figure 14: Global Market Volume (Units) Analysis by Disease Pathology, 2019 to 2034

Figure 15: Global Market Value Share (%) and BPS Analysis by Disease Pathology, 2024 to 2034

Figure 16: Global Market Y-o-Y Growth (%) Projections by Disease Pathology, 2024 to 2034

Figure 17: Global Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 18: Global Market Volume (Units) Analysis by End-User, 2019 to 2034

Figure 19: Global Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 20: Global Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 21: Global Market Attractiveness by Device, 2024 to 2034

Figure 22: Global Market Attractiveness by Disease Pathology, 2024 to 2034

Figure 23: Global Market Attractiveness by End-User, 2024 to 2034

Figure 24: Global Market Attractiveness by Region, 2024 to 2034

Figure 25: North America Market Value (US$ Million) by Device, 2024 to 2034

Figure 26: North America Market Value (US$ Million) by Disease Pathology, 2024 to 2034

Figure 27: North America Market Value (US$ Million) by End-User, 2024 to 2034

Figure 28: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 29: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 30: North America Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 33: North America Market Value (US$ Million) Analysis by Device, 2019 to 2034

Figure 34: North America Market Volume (Units) Analysis by Device, 2019 to 2034

Figure 35: North America Market Value Share (%) and BPS Analysis by Device, 2024 to 2034

Figure 36: North America Market Y-o-Y Growth (%) Projections by Device, 2024 to 2034

Figure 37: North America Market Value (US$ Million) Analysis by Disease Pathology, 2019 to 2034

Figure 38: North America Market Volume (Units) Analysis by Disease Pathology, 2019 to 2034

Figure 39: North America Market Value Share (%) and BPS Analysis by Disease Pathology, 2024 to 2034

Figure 40: North America Market Y-o-Y Growth (%) Projections by Disease Pathology, 2024 to 2034

Figure 41: North America Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 42: North America Market Volume (Units) Analysis by End-User, 2019 to 2034

Figure 43: North America Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 44: North America Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 45: North America Market Attractiveness by Device, 2024 to 2034

Figure 46: North America Market Attractiveness by Disease Pathology, 2024 to 2034

Figure 47: North America Market Attractiveness by End-User, 2024 to 2034

Figure 48: North America Market Attractiveness by Country, 2024 to 2034

Figure 49: Latin America Market Value (US$ Million) by Device, 2024 to 2034

Figure 50: Latin America Market Value (US$ Million) by Disease Pathology, 2024 to 2034

Figure 51: Latin America Market Value (US$ Million) by End-User, 2024 to 2034

Figure 52: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 53: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 54: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 57: Latin America Market Value (US$ Million) Analysis by Device, 2019 to 2034

Figure 58: Latin America Market Volume (Units) Analysis by Device, 2019 to 2034

Figure 59: Latin America Market Value Share (%) and BPS Analysis by Device, 2024 to 2034

Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Device, 2024 to 2034

Figure 61: Latin America Market Value (US$ Million) Analysis by Disease Pathology, 2019 to 2034

Figure 62: Latin America Market Volume (Units) Analysis by Disease Pathology, 2019 to 2034

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Disease Pathology, 2024 to 2034

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Disease Pathology, 2024 to 2034

Figure 65: Latin America Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 66: Latin America Market Volume (Units) Analysis by End-User, 2019 to 2034

Figure 67: Latin America Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 68: Latin America Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 69: Latin America Market Attractiveness by Device, 2024 to 2034

Figure 70: Latin America Market Attractiveness by Disease Pathology, 2024 to 2034

Figure 71: Latin America Market Attractiveness by End-User, 2024 to 2034

Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 73: Western Europe Market Value (US$ Million) by Device, 2024 to 2034

Figure 74: Western Europe Market Value (US$ Million) by Disease Pathology, 2024 to 2034

Figure 75: Western Europe Market Value (US$ Million) by End-User, 2024 to 2034

Figure 76: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 77: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 78: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 79: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 80: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 81: Western Europe Market Value (US$ Million) Analysis by Device, 2019 to 2034

Figure 82: Western Europe Market Volume (Units) Analysis by Device, 2019 to 2034

Figure 83: Western Europe Market Value Share (%) and BPS Analysis by Device, 2024 to 2034

Figure 84: Western Europe Market Y-o-Y Growth (%) Projections by Device, 2024 to 2034

Figure 85: Western Europe Market Value (US$ Million) Analysis by Disease Pathology, 2019 to 2034

Figure 86: Western Europe Market Volume (Units) Analysis by Disease Pathology, 2019 to 2034

Figure 87: Western Europe Market Value Share (%) and BPS Analysis by Disease Pathology, 2024 to 2034

Figure 88: Western Europe Market Y-o-Y Growth (%) Projections by Disease Pathology, 2024 to 2034

Figure 89: Western Europe Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 90: Western Europe Market Volume (Units) Analysis by End-User, 2019 to 2034

Figure 91: Western Europe Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 93: Western Europe Market Attractiveness by Device, 2024 to 2034

Figure 94: Western Europe Market Attractiveness by Disease Pathology, 2024 to 2034

Figure 95: Western Europe Market Attractiveness by End-User, 2024 to 2034

Figure 96: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 97: Eastern Europe Market Value (US$ Million) by Device, 2024 to 2034

Figure 98: Eastern Europe Market Value (US$ Million) by Disease Pathology, 2024 to 2034

Figure 99: Eastern Europe Market Value (US$ Million) by End-User, 2024 to 2034

Figure 100: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 101: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 102: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 103: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 104: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 105: Eastern Europe Market Value (US$ Million) Analysis by Device, 2019 to 2034

Figure 106: Eastern Europe Market Volume (Units) Analysis by Device, 2019 to 2034

Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Device, 2024 to 2034

Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Device, 2024 to 2034

Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Disease Pathology, 2019 to 2034

Figure 110: Eastern Europe Market Volume (Units) Analysis by Disease Pathology, 2019 to 2034

Figure 111: Eastern Europe Market Value Share (%) and BPS Analysis by Disease Pathology, 2024 to 2034

Figure 112: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease Pathology, 2024 to 2034

Figure 113: Eastern Europe Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 114: Eastern Europe Market Volume (Units) Analysis by End-User, 2019 to 2034

Figure 115: Eastern Europe Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 116: Eastern Europe Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 117: Eastern Europe Market Attractiveness by Device, 2024 to 2034

Figure 118: Eastern Europe Market Attractiveness by Disease Pathology, 2024 to 2034

Figure 119: Eastern Europe Market Attractiveness by End-User, 2024 to 2034

Figure 120: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 121: South Asia and Pacific Market Value (US$ Million) by Device, 2024 to 2034

Figure 122: South Asia and Pacific Market Value (US$ Million) by Disease Pathology, 2024 to 2034

Figure 123: South Asia and Pacific Market Value (US$ Million) by End-User, 2024 to 2034

Figure 124: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 125: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 126: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 127: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 128: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 129: South Asia and Pacific Market Value (US$ Million) Analysis by Device, 2019 to 2034

Figure 130: South Asia and Pacific Market Volume (Units) Analysis by Device, 2019 to 2034

Figure 131: South Asia and Pacific Market Value Share (%) and BPS Analysis by Device, 2024 to 2034

Figure 132: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Device, 2024 to 2034

Figure 133: South Asia and Pacific Market Value (US$ Million) Analysis by Disease Pathology, 2019 to 2034

Figure 134: South Asia and Pacific Market Volume (Units) Analysis by Disease Pathology, 2019 to 2034

Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Disease Pathology, 2024 to 2034

Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Disease Pathology, 2024 to 2034

Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 138: South Asia and Pacific Market Volume (Units) Analysis by End-User, 2019 to 2034

Figure 139: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 140: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 141: South Asia and Pacific Market Attractiveness by Device, 2024 to 2034

Figure 142: South Asia and Pacific Market Attractiveness by Disease Pathology, 2024 to 2034

Figure 143: South Asia and Pacific Market Attractiveness by End-User, 2024 to 2034

Figure 144: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 145: East Asia Market Value (US$ Million) by Device, 2024 to 2034

Figure 146: East Asia Market Value (US$ Million) by Disease Pathology, 2024 to 2034

Figure 147: East Asia Market Value (US$ Million) by End-User, 2024 to 2034

Figure 148: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 149: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 150: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 151: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 152: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 153: East Asia Market Value (US$ Million) Analysis by Device, 2019 to 2034

Figure 154: East Asia Market Volume (Units) Analysis by Device, 2019 to 2034

Figure 155: East Asia Market Value Share (%) and BPS Analysis by Device, 2024 to 2034

Figure 156: East Asia Market Y-o-Y Growth (%) Projections by Device, 2024 to 2034

Figure 157: East Asia Market Value (US$ Million) Analysis by Disease Pathology, 2019 to 2034

Figure 158: East Asia Market Volume (Units) Analysis by Disease Pathology, 2019 to 2034

Figure 159: East Asia Market Value Share (%) and BPS Analysis by Disease Pathology, 2024 to 2034

Figure 160: East Asia Market Y-o-Y Growth (%) Projections by Disease Pathology, 2024 to 2034

Figure 161: East Asia Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 162: East Asia Market Volume (Units) Analysis by End-User, 2019 to 2034

Figure 163: East Asia Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 164: East Asia Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 165: East Asia Market Attractiveness by Device, 2024 to 2034

Figure 166: East Asia Market Attractiveness by Disease Pathology, 2024 to 2034

Figure 167: East Asia Market Attractiveness by End-User, 2024 to 2034

Figure 168: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 169: Middle East and Africa Market Value (US$ Million) by Device, 2024 to 2034

Figure 170: Middle East and Africa Market Value (US$ Million) by Disease Pathology, 2024 to 2034

Figure 171: Middle East and Africa Market Value (US$ Million) by End-User, 2024 to 2034

Figure 172: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 173: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 174: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 177: Middle East and Africa Market Value (US$ Million) Analysis by Device, 2019 to 2034

Figure 178: Middle East and Africa Market Volume (Units) Analysis by Device, 2019 to 2034

Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Device, 2024 to 2034

Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Device, 2024 to 2034

Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Disease Pathology, 2019 to 2034

Figure 182: Middle East and Africa Market Volume (Units) Analysis by Disease Pathology, 2019 to 2034

Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Pathology, 2024 to 2034

Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Pathology, 2024 to 2034

Figure 185: Middle East and Africa Market Value (US$ Million) Analysis by End-User, 2019 to 2034

Figure 186: Middle East and Africa Market Volume (Units) Analysis by End-User, 2019 to 2034

Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by End-User, 2024 to 2034

Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-User, 2024 to 2034

Figure 189: Middle East and Africa Market Attractiveness by Device, 2024 to 2034

Figure 190: Middle East and Africa Market Attractiveness by Disease Pathology, 2024 to 2034

Figure 191: Middle East and Africa Market Attractiveness by End-User, 2024 to 2034

Figure 192: Middle East and Africa Market Attractiveness by Country, 2024 to 2034